Corbus Pharmaceuticals' IPO

Corbus Pharmaceuticals raised a round of funding on October 28, 2014. Investors include Public.

Corbus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening ("orphan") inflammatory-fibrotic d…

Articles about Corbus Pharmaceuticals' IPO: